Anoro Ellipta Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per 62.5 mcg/25 mcg DPI Umeclidinium Br 62.5 mcg (equiv to 55 mcg), vilanterol trifenatate 25 mcg (equiv to 22 mcg)

Indications/Uses

Maintenance bronchodilator treatment to relieve symptoms associated w/ COPD.

Click to view Anoro Ellipta detailed prescribing information

Dosage/Direction for Use

Adult 1 inhalation once daily at the same time each day.

Click to view Anoro Ellipta detailed prescribing information

Overdosage

View Anoro Ellipta overdosage for action to be taken in the event of an overdose.

Contraindications

Severe milk-protein allergy.

Click to view Anoro Ellipta detailed prescribing information

Special Precautions

Not recommended in patients w/ asthma. Not for the relief of acute symptoms ie, rescue therapy for the treatment of bronchospasm. Discontinue use if paradoxical bronchospasm occurs. Severe CV disease; narrow-angle glaucoma or urinary retention. Pregnancy & lactation. Childn <18 yr.

Click to view Anoro Ellipta detailed prescribing information

Use In Pregnancy & Lactation

Click to view Anoro Ellipta detailed prescribing information

Adverse Reactions

UTI, sinusitis, nasopharyngitis, pharyngitis, upper resp tract infection; cough, oropharyngeal pain; constipation, dry mouth.

Click to view Anoro Ellipta detailed prescribing information

Drug Interactions

Vilanterol: May weaken or antagonize effect w/ either nonselective or selective β-adrenergic blockers. Increased systemic exposure w/ strong CYP3A4 inhibitors (eg, ketoconazole).

Click to view Anoro Ellipta detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Anoro Ellipta detailed prescribing information

Storage

View Anoro Ellipta storage conditions for details to ensure optimal shelf-life.

Description

View Anoro Ellipta description for details of the chemical structure and excipients (inactive components).

Action

View Anoro Ellipta mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AL03 - vilanterol and umeclidinium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

Anoro Ellipta 62.5 mcg/25 mcg DPI

Packing/Price

30 dose x 1's

Anoro Ellipta

umeclidinium + vilanterol

Manufacturer:

GlaxoSmithKline

Distributor:

GlaxoSmithKline